Medication management platform provider Medisafe is working with Nestlé Health Science to help with compliance to the proper regimen of IMPACT ADVANCED RECOVERY Specialized Nutrition Drink to address the nutritional needs of major elective surgery patients at risk of infection.
The two companies will work with clinical teams at a number of major U.S. hospital systems to help patients install Medisafe on their smart devices when their treating physicians recommend IMPACT ADVANCED RECOVERY Drink. Those that accept the scheme will receive Medisafe alerts reminding them when it’s time for each recommended serving, along with access to all Medisafe features and functionality, including management of any medications, “Medfriend” caregiver support, and a feed of additional content and resources tailored to their individual circumstances. In addition, the service will also display educational content provided by Nestlé Health Science.
“This partnership comes on the heels of our recent Medisafe Providers launch, showing our commitment to build tools within the platform for physicians and care teams to support their patients’ compliance on an ongoing basis,” Jon Michaeli, Medisafe’s EVP Marketing and Business Development, said in a statement.
This collaboration with Nestlé Health Science initially focuses on the five-to-ten day preoperative window (before and after surgery) for major elective surgery patients.
Nestlé Health Science is also bullish about the deal with Medisafe; the company’s President of Medical Nutrition Marketing North America said that the Medisafe app has the potential to “significantly increase adherence to the IMPACT protocol that is recommended for certain major elective surgery patients by their healthcare professionals.”
Nestlé has also recently partnered with Medidata to use their platform to conduct a two-year clinical trial in China, to evaluate the impact of nutrition combined with physical activity on mobility in healthy aging adults with joint discomfort.